Form 4 Filing for BIO-TECHNE Corp by James Hippel

This filing details stock transactions by James Hippel, CFO of BIO-TECHNE Corp. On July 29, 2026, Hippel acquired 62,068 shares of common stock at $47.60 per share, increasing his post-transaction holdings to 215,738 shares. In a separate transaction on the same day, he disposed of 51,024 shares at $72.03 per share, resulting in 164,714 shares remaining. The filing also reports on various stock options and restricted stock units, including their vesting schedules and exercise prices, with transactions indicating both acquisitions and disposals of these derivative securities. The reporting owner, James Hippel, is identified with CIK 0001603594.